End of Content.
In Stock
BPC-157 is a 15-amino-acid peptide fragment derived from a protective gastric protein sequence. It has been characterized in the research literature for studies in cellular migration, angiogenesis, tendon and ligament research models, and gut-lining research. Nova supplies BPC-157 in three formats: a 5mg lyophilized vial, a 10mg lyophilized vial, and a 500mcg pre-measured dry-fill research unit. Lyophilized vials require reconstitution with a suitable solvent such as Bacteriostatic Water before research use. Dry-fill units are supplied pre-measured for protocols requiring discrete fixed quantities without solvent-preparation steps. Every batch is triple-tested by an independent, ISO/IEC 17025-accredited laboratory (purity via HPLC, identity via MS, concentration quantitatively, endotoxins via LAL). Every vial and dry-fill container carries a QR code linked to its batch Certificate of Analysis. For research use only. Not for human or animal consumption.
| Size | 5MG, 10MG |
|---|
ERR (estrogen-related receptor) pan-agonist. Studied in metabolic, mitochondrial-function, and energy-expenditure research. Supplied as…
Alpha-MSH tripeptide fragment (Lys-Pro-Val) in dry-fill capsule format. Studied in inflammatory-pathway and gut-epithelial…
NNMT (nicotinamide N-methyltransferase) inhibitor, 5-amino-1-methylquinolinium. Studied in metabolic and mitochondrial-pathway research. NNMT inhibitor…
